Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter C Enzinger

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Lynette Cederquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
Metastatic colon cancer, version 3.2013: featured updates to the NCCN GuidelinesAl B Benson, Tanios Bekaii-Saab, Emily Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Colon cancer, version 3.2014Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Rectal Cancer, Version 2.2015Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
The Lancet. Oncology|July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trialDaniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of the National Comprehensive Cancer Network : JNCCN|March 10, 2017
Colon Cancer, Version 1.2017, NCCN Clinical Practice Guidelines in OncologyAl B Benson, Alan P Venook, Lynette Cederquist, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 16, 2013
Metastatic colon cancer, version 3.2013: featured updates to the NCCN GuidelinesAl B Benson, Tanios Bekaii-Saab, Emily Chan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 5, 2014
Colon cancer, version 3.2014Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Rectal Cancer, Version 2.2015Al B Benson, Alan P Venook, Tanios Bekaii-Saab, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2022
Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 19, 2019
Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|April 4, 2023
Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
The Lancet. Oncology|July 13, 2020
Margetuximab plus pembrolizumab in patients with previously treated, HER2-positive gastro-oesophageal adenocarcinoma (CP-MGAH22-05): a single-arm, phase 1b-2 trialDaniel V T Catenacci, Yoon-Koo Kang, Haeseong Park, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 9, 2025
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyJaffer A Ajani, Thomas A D'Amico, David J Bentrem, et al.
JCO Precision Oncology|January 12, 2023
Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal CancerRachel B Keller, Tali Mazor, Lynette Sholl, et al.
Pageof 10